Argentina starts trials on hyperimmune equine serum
Argentina on Wednesday began clinical trials for treating COVID-19 with hyperimmune equine serum. The serum, produced by biotechnology company Inmunova, is developed with antibodies from horses, lab officials said. A total of 242 coronavirus patients with moderate to severe conditions will participate in the trial.
Sign Up for Mideast Daily News
Wake up to the Trusted Mideast News source
By subscribing, you agree to The Media Line terms of use and privacy policy.